Delivery Order SPE2DB20D1100-SPE2DB25FE1CK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Sorafenib 200 mg tablets (120-count) with a ceiling value of $7,385.11. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sorafenib 200 mg tablets (120-count) with a ceiling value of $45,892.39. This firm fixed-price delivery order, awarded on September 11, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,736 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexavar 200 mg tablets (120 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,272.22 firm fixed-price delivery order is for the provision of 120 tablets of the drug Sorafenib 200 mg. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $56,333.26 firm-fixed-price delivery order is for the supply of Sorafenib 200 mg tablets. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award, valued at $16,253.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564742986 - Sorafenib 200 mg Tablets in 120-count bottles, with a completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $84,773.77 firm fixed-price delivery order is for the supply of 4,558,627,779 units of Sorafenib 200 mg tablets. The contract has a completion date of September 29, 2022 and was awarded on September 28, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded several...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) with a ceiling value of $9,141.79. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $37,245.18 to AmerisourceBergen Drug Corp for the supply of Sunitinib Malate 25 mg capsules (28-count units). This competitively awarded contract, issued on September 25, 2025, with a completion date of September 26, 2025, represents a firm fixed price delivery order with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,543.70 by the Defense Logistics Agency on September 11, 2025, with completion expected by October 2, 2025. The contract calls for the supply of Lynparza 100 mg tablets in quantities of 60 units, a targeted oncology medication used in cancer treatment. The award was made on a firm fixed-price basis without set-aside designation, indicating...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1CKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Sorafenib 200 mg tablets (120-count units) with a ceiling value of $14,770.22. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a routine pharmaceutical procurement from AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical supply chains. As a critical vendor for military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The underlying IDC framework enables the company to fulfill diverse federal medical procurement requirements efficiently, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting vehicle designed to meet worldwide military healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 9/25/25 |